1. Home
  2. AAPG vs HEPS Comparison

AAPG vs HEPS Comparison

Compare AAPG & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$14.85

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo D-Market Electronic Services & Trading

HEPS

D-Market Electronic Services & Trading

N/A

Current Price

$2.78

Market Cap

1.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
AAPG
HEPS
Founded
2009
2000
Country
China
Turkey
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
AAPG
HEPS
Price
$14.85
$2.78
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
★ $44.50
$3.29
AVG Volume (30 Days)
4.6K
★ 180.4K
Earning Date
08-19-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.59
$34.24
Revenue Next Year
$120.05
$29.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.46
$2.15
52 Week High
$34.50
$3.30

Technical Indicators

Market Signals
Indicator
AAPG
HEPS
Relative Strength Index (RSI) 44.47 62.27
Support Level $14.50 $2.74
Resistance Level $16.34 $2.93
Average True Range (ATR) 0.46 0.07
MACD 0.06 0.01
Stochastic Oscillator 15.04 97.37

Price Performance

Historical Comparison
AAPG
HEPS

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.

Share on Social Networks: